Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carters (CRI) Common Equity (2016 - 2026)

Carters (CRI) has disclosed Common Equity for 18 consecutive years, with $925.0 million as the latest value for Q1 2026.

  • Quarterly Common Equity rose 8.25% to $925.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $925.0 million through Jan 2026, up 8.25% year-over-year, with the annual reading at $925.0 million for FY2026, 8.25% up from the prior year.
  • Common Equity for Q1 2026 was $925.0 million at Carters, up from $864.6 million in the prior quarter.
  • The five-year high for Common Equity was $950.2 million in Q1 2022, with the low at $775.0 million in Q3 2023.
  • Average Common Equity over 5 years is $841.3 million, with a median of $841.4 million recorded in 2024.
  • The sharpest move saw Common Equity decreased 25.28% in 2022, then grew 8.25% in 2026.
  • Over 5 years, Common Equity stood at $796.4 million in 2022, then grew by 6.13% to $845.2 million in 2023, then grew by 1.1% to $854.6 million in 2024, then increased by 1.18% to $864.6 million in 2025, then grew by 6.99% to $925.0 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods came in at $925.0 million, $864.6 million, and $853.9 million for Q1 2026, Q3 2025, and Q2 2025 respectively.